title: Raising serum gastrin to improve glycemic control in (type 2) diabetes: another limb of the enteroinsular axis?
authors.forename: Michael R
authors.initials: MR
authors.lastname: Rickels
authors.forename: Dariush
authors.initials: D
authors.lastname: Elahi
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D054328:Proton Pump Inhibitors; D000077402:Pantoprazole